Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases [Phase 1]
Phase 1 clinical trial update for HER2-directed CAR-T cells in patients with recurrent brain or leptomeningeal metastases from breast cancer…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
This clinical trial update describes an observational study sponsored by Hoffmann-La Roche to describe diagnosis, anti-cancer treatment patt…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) [Phase 3]
A Phase 3 trial (DEBRA) assesses de-escalation of breast radiation in hormone receptor-positive, HER2-negative breast cancer with Oncotype R…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Preoperative Sleep Quality and Postoperative Outcomes in Breast Surgery
A clinical trial is assessing whether preoperative sleep quality affects postoperative outcomes in breast cancer surgery, with recruitment c…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Phase IIIb Study of Ribociclib + ET in Early Breast Cancer [Phase 3]
This entry describes an ongoing Phase 3b clinical trial evaluating ribociclib in combination with endocrine therapy for early-stage breast c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymorphisms [Phase 2, Phase 3]
This clinical trial update describes an ongoing Phase 2/Phase 3 study sponsored by Han Xu evaluating raloxifene with respect to single nucle…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Auricular Laser Acupuncture for Improving Sleep in Breast Cancer Patients [NA]
This ClinicalTrials.gov entry describes a study evaluating auricular laser acupuncture to improve sleep in female breast cancer patients wit…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: E-Mindfulness Approaches for Living After Breast Cancer [Phase 3]
This document describes a Phase 3 clinical trial called E-Mindfulness Approaches for Living After Breast Cancer, sponsored by NRG Oncology, …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
A first-in-human study of tersolisib (STX-478) as monotherapy and in combination with other anticancer agents in adults with advanced solid …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Overcoming Racial Disparities in Screening Mammography [NA]
A clinical trial update describing a study aimed at addressing racial disparities in breast cancer screening with mammography, currently not…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study
The OPBC-11/MACRONAC clinical trial investigates whether axillary lymph node dissection is appropriate for residual macrometastases after ne…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials [NA]
A pilot clinical trial called 'Just ASK' aims to increase discussions about breast cancer clinical trials and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Phase Ib/II Study of Zanidatamab Plus Tucatinib and Chemotherapy in HER2-Positive Advanced Breast Cancer [Phase 1, Phase 2]
Phase Ib/II clinical trial evaluating zanidatamab in combination with tucatinib and chemotherapy for HER2-positive advanced breast cancer; s…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer) [Phase 3]
Phase 3 clinical trial update evaluating giredestrant for ER+/HER2- early breast cancer in participants intolerant to adjuvant aromatase inh…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Endoscopic Skin-Sparing vs. Conventional Mastectomy for Wound Complications in BC [NA]
This clinical trial is an ongoing study comparing endoscopic skin-sparing mastectomy to conventional mastectomy, with current recruitment fo…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer [Phase 3]
A Phase 3 trial is evaluating camrelizumab in combination with apatinib and eribulin versus physician's choice chemotherapy in metastatic tr…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea
A Korea-based clinical trial is evaluating trastuzumab emtansine (T-DM1) after prior treatment with trastuzumab deruxtecan (T-DXd) in HER2-p…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients [NA]
A clinical trial update for a telehealth resistance exercise program designed to preserve dose intensity and vitality in older women with br…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 [Phase 3]
This Phase 3 trial by NRG Oncology is evaluating whether adding adjuvant chemotherapy to ovarian function suppression plus endocrine therapy…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors [NA]
NRG Oncology is recruiting a trial to evaluate cognitive training for cancer-related cognitive impairment in breast cancer survivors (NCT058…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Intraoperative Margin Assessment in Breast Cancer With HSI-Raman
Clinical trial evaluating intraoperative margin assessment in breast cancer using hyperspectral imaging and Raman spectroscopy is currently …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Social Media-Based Education on Cancer Screening Awareness in Women: A Randomized Controlled Trial [NA]
This clinical trial update describes a randomized controlled trial evaluating a social media-based education program to raise awareness abou…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells [Phase 1]
Phase 1 study of autologous CAR-T cells targeting B7-H3 (iC9-CAR.B7-H3 T Cells) for triple-negative breast cancer; the trial is currently re…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Sacituzumab Govitecan in Primary HER2-negative Breast Cancer [Phase 3]
A Phase 3 trial of sacituzumab govitecan in primary HER2-negative breast cancer (including triple-negative breast cancer) is currently activ…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study [Phase 2]
A Phase 2 clinical trial is studying individualized approaches to surveillance mammography for older breast cancer survivors, known as the I…